Dose-finding for Dobutamine During Transitional Circulation in Very Preterm Infants
Status:
RECRUITING
Trial end date:
2029-06-01
Target enrollment:
Participant gender:
Summary
Single centre, dose finding trial to establish the minimum effective dose of dobutamine required to treat hemodynamic insufficiency, defined as low superior vena cava (SVC) flow, in infants below 33 weeks' gestation during transitional circulation (first 72 hours from birth).
Phase:
PHASE1
Details
Lead Sponsor:
Instituto de Investigacin Hospital Universitario La Paz